Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06353256 · ClinicalTrials.gov registry record · NA
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
A NA study of Preeclampsia Postpartum and Adverse Pregnancy Outcomes, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 2
- Study locations
NCT06353256: Completed NA study of Preeclampsia Postpartum and Adverse Pregnancy Outcomes, sponsored by University of Alabama at Birmingham.
NCT06353256 is a NA study of Preeclampsia Postpartum and Adverse Pregnancy Outcomes that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 61 participants, roughly in line with the 67-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06353256, a NA study of Preeclampsia Postpartum and Adverse Pregnancy Outcomes, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 2
- Study locations
Study Summary
United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal community health worker intervention for Black postpartum patients with preeclampsia (PE) and other adverse pregnancy outcomes (APOs). Investigators will partner with a community-based organization that trains and deploys community health workers. Investigators will test an intervention for urban and rural Black postpartum patients with APOs to 1) enhance blood pressure control postpartum and 2) promote long-term cardiovascular disease prevention for this underserved population. This pilot study will determine if randomizing and implementing a community health worker intervention tailored to pregnant people experiencing preeclampsia is feasible and found to be acceptable by participants.
Primary Outcome
Participant satisfaction with postpartum support received as part of the study (scaled from 1 to 10). Participant satisfaction with postpartum support received as part of the study, measured on a 1 to 10 scale where 1 = lowest satisfaction and 10 = highest satisfaction. Higher scores represent greater satisfaction (a better outcome).
Conditions Studied
Interventions
- BEHAVIORAL usual postpartum care
- BEHAVIORAL usual postpartum care + community health worker intervention
Study Locations (2)
Alabama
- UAB Medicine - Birmingham
- The University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2025-06-02 |
| Phase | NA |
What the finished NCT06353256 record still lists
NCT06353256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, roughly in line with the 67-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target.
The record links to 2 conditions, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 2 interventions - of which usual postpartum care is the first listed.
NCT06353256 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06353256 about?
NCT06353256 is a clinical study titled "A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes". United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal communit...
What is the current status of trial NCT06353256?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2024-09-03. Estimated completion is 2025-06-02.
What conditions does trial NCT06353256 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum, Adverse Pregnancy Outcomes.
What interventions are being tested in trial NCT06353256?
The interventions under investigation include: usual postpartum care (BEHAVIORAL), usual postpartum care + community health worker intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06353256?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06353256 being conducted?
This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06353256's enrollment target sits among peer trials
61 4th of 8 higher than 5 of 8 other Preeclampsia Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
ACTIVE NOT RECRUITING · NA
-
Aspirin for Postpartum Patients With Preeclampsia
RECRUITING · Phase 2
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Aspirin and Preeclampsia
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI